Re: New discussion-PE: Is it improving medicine affordability?

[Guest guest]

On Sun, Jun 13, 2010 at 12:23 PM, anupama sukhlecha <anupama_acad@...> wrote:

 

   

      Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

 

   

Did you mean " despite " or " because of " ?/ArinNZ 

[Guest guest]

Dear All,A very relevant discussion, specially relevant in light of the increasing cost of drugs and their rising share in the total cost of therapy. I would suggest that we discuss this in sub-headings as whenever this issue is discussed we tend to clump all categories of drugs together and the discussion becomes an emotionally charged talk against profit-making TNCs. So I think we should start with the basic life saving drugs and evaluating their pricing and suggest means to minimize cost and then move on to the recently introduced drugs and discuss their pricing in light of development costs and other costs.

Regards,ArifOn Sun, Jun 13, 2010 at 5:53 AM, anupama sukhlecha <anupama_acad@...> wrote:

 

Dear NetRUMians,

    Welcome to all of you on another topic of discussion. I am Dr Anupama, Assistant Professor in Pharmacology at Jamnagar. I shall be moderating this new topic " PE: Is it improving medicine affordability " for the next few days.

 

Background:

   In low and middle-income countries a large proportion of the population live in poverty and their condition is characterized by high rates of mortality, morbidity and disability, as well as limited access or none to health care and services. Prescription drug costs have risen rapidly in the last decade. Inability to pay for medications has consequences for population health and health system costs. A large population of India is unable to afford the prescribed medicines. There are plenty of cases of cost-associated noncompliance.

   

      Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

 

   

On the first day of our discussion, let us look at the problems which influence availability and affordability of medicines.

 

Surprise gifts assured for active contributors of discussion!

 

Waiting for your valuable inputs

Anupama Sukhlecha

Jamnagar

-- Dr. Arif Hashmidrarifhashmi@...

[Guest guest]

Dear Dr Arin,

There is a need for medicines in both poor and rich countries, but consumption is more in rich countries because of health awareness and medicine affordability.

Anupama

Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

Did you mean "despite" or "because of" ?

/Arin

NZ

[Guest guest]

On Mon, Jun 14, 2010 at 5:02 AM, anupama sukhlecha <anupama_acad@...> wrote:

 

 Dear Dr Arin,

    There is a need for medicines in both poor and rich countries, but consumption is more in rich countries because of health awareness and medicine affordability.

----Thanks for this information.,/Arin

Anupama

 

   

      Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

 

   

Did you mean " despite " or " because of " ?

/Arin

NZ 

[Guest guest]

Namaste allI think the present topic is of utmost importance because it has the potential to topple off any system of health care. The core point is that, everywhere, we adopted a system which is primarily medicine-centered. In order to make a shift in outcome, we should make a shift in the approach. Because we cannot expect a different result if we keep on doing the same thing again and again. Our approach towards health should be lifestyle-centered basically. Medical healing should be confined to the areas of emergencies. Otherwise, as the morbidity indices are on a regular high, the medical expenses in the monthly budget of common men will remain on an upward graph. With wishes & prayers for ayurarogyasoukhyamVaidya Prasad M.Director Sunethri Ayurvedashram, Thrissur, KeralaFrom: anupama sukhlecha <anupama_acad@...>Subject: New

discussion-PE: Is it improving medicine affordability?netrum Date: Sunday, 13 June, 2010, 5:53 AM

Dear NetRUMians,

Welcome to all of you on another topic of discussion. I am Dr Anupama, Assistant Professor in Pharmacology at Jamnagar. I shall be moderating this new topic "PE: Is it improving medicine affordability" for the next few days.

Background:

In low and middle-income countries a large proportion of the population live in poverty and their condition is characterized by high rates of mortality, morbidity and disability, as well as limited access or none to health care and services. Prescription drug costs have risen rapidly in the last decade. Inability to pay for medications has consequences for population health and health system costs. A large population of India is unable to afford the prescribed medicines. There are plenty of cases of cost-associated noncompliance.

Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

On the first day of our discussion, let us look at the problems which influence availability and affordability of medicines.

Surprise gifts assured for active contributors of discussion!

Waiting for your valuable inputs

Anupama Sukhlecha

Jamnagar

[Guest guest]

It was very interesting to read Vaidya Prasad's reflection. Here's what he wrote I found really interesting:

On Mon, Jun 14, 2010 at 9:24 PM, Vaidya Prasad M <ayur_eye@...> wrote:

 

.... Because we cannot expect a different result if we keep on doing the same thing again and again.  Our approach towards health should be lifestyle-centered basically.  ...

I'd like to write a few words on this statement from the perspective of life course or health care across life span and see if this resonates with what he has written. There has been much interest in life course health development and life course epidemiological approaches among epidemiologists and health policy specialists. Essentially, according to life course approach, events that take place or exposures that occur at the time of fetal development at specific time points (termed as " sensitive periods " ) can impact late life development of disease (examples include Barker's hypothesis of heart disease or epidemiological investigations of phocomelia as a result of prenatal exposure to thalidomide, or even loose examples such as development of vaginal adenocarcinoma among offsprings of women who were prescribed diethyl stilboesterol, but also studies on insulin resistance among infants with low nutirition during developmental phases and late life development of type II DM: intriguing studies). Lately, this concept has been expanded to include theories of how life course affects trajectories of life. By trajectories of life is meant when a child is born, he or she is in a given state of health pretty much as a function of genetic endowments and environmental impacts. As life goes on, environmental impacts and genetic constitution interact across the life span of this individual and it happens throughout the life span of the individual, taking into different trajectories of life. This somewhat relates to the concept of health/disease more than a state. Tjhe life course health development approach thus talks about influence of developmental science on the states of disease or health of individuals throughout their life spans.

Seems to me this is where pharmacological interventions and choosing a balance between pharmacological and non-pharmacological interventions and correct mix between understanding individual characteristics, environmental endowments, and lifestyle issues play a crucial role. Tne nature of cost effectiveness analysis need to take into account the more holistic notions of health than how we measure quality of life (quality adjusted life years for example is heavily influenced by what is meant by quality; similarly studies on health related quality of life often captured by one time cross sectional surveys often miss the essential mutability of life trajectories).

I'd probably interpret " lifestyle oriented " as a term that acknowledges the importance of developing life trajectories and life span approach. Very interested to see this discussion here.Best,

Arin 

From: anupama sukhlecha <anupama_acad@...>Subject: New

discussion-PE: Is it improving medicine affordability?netrum Date: Sunday, 13 June, 2010, 5:53 AM

 

Dear NetRUMians,

    Welcome to all of you on another topic of discussion. I am Dr Anupama, Assistant Professor in Pharmacology at Jamnagar. I shall be moderating this new topic " PE: Is it improving medicine affordability " for the next few days.

 

Background:

   In low and middle-income countries a large proportion of the population live in poverty and their condition is characterized by high rates of mortality, morbidity and disability, as well as limited access or none to health care and services. Prescription drug costs have risen rapidly in the last decade. Inability to pay for medications has consequences for population health and health system costs. A large population of India is unable to afford the prescribed medicines. There are plenty of cases of cost-associated noncompliance.

   

      Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

 

   

On the first day of our discussion, let us look at the problems which influence availability and affordability of medicines.

 

Surprise gifts assured for active contributors of discussion!

 

Waiting for your valuable inputs

Anupama Sukhlecha

Jamnagar

[Guest guest]

Dear Dr.ArinThank you for commenting on the point which I raised. Unfortunately our moderator took it in a very light sense, if I am right, as reflected in her words, quote, "medicine system should be holistic. An

integrative approach comrising of all systems of medicine like

Ayurveda, Allopathic, Homeopathic, Siddha, Chinese...should be adopted." unquote. She misinterprets holism (which itself is an obsolete word) as an integration of all systems!! I can suggest a beautiful book for further reading to the group members. title: WHAT DOCTORS DON'T GET TO STUDY IN MEDICAL SCHOOLSautjor: Dr. B M HEGDEPub: PARAS, HYDERABADWith wishes & prayers Vaidya Prasad M.

From: anupama sukhlecha <anupama_acad@ .co. in>Subject: New

discussion-PE: Is it improving medicine affordability?netrumgroups (DOT) comDate: Sunday, 13 June, 2010, 5:53 AM

Dear NetRUMians,

Welcome to all of you on another topic of discussion. I am Dr Anupama, Assistant Professor in Pharmacology at Jamnagar. I shall be moderating this new topic "PE: Is it improving medicine affordability" for the next few days.

Background:

In low and middle-income countries a large proportion of the population live in poverty and their condition is characterized by high rates of mortality, morbidity and disability, as well as limited access or none to health care and services. Prescription drug costs have risen rapidly in the last decade. Inability to pay for medications has consequences for population health and health system costs. A large population of India is unable to afford the prescribed medicines. There are plenty of cases of cost-associated noncompliance.

Despite the increased world consumption of medicines, problems remain in ensuring the availability and affordability of medicines, including those which are essential for treating the majority of common diseases prevailing in low and middle-income countries.

On the first day of our discussion, let us look at the problems which influence availability and affordability of medicines.

Surprise gifts assured for active contributors of discussion!

Waiting for your valuable inputs

Anupama Sukhlecha

Jamnagar

[Guest guest]

dear all====in addition to suggested this book-----1]google search on

WHAT DOCTOR DO"NT TELL YOU AND FIND WEB SITE WWW>WDDTUVIP which

also delivers TELESEMINARs which we may see through web conference of

BSNL>INDIA.2] see the textbook of physiology by dr r.l. bijalani 3rd

edition==last chapter of book WHAT EVERY DOCTOR SHOULD KNOW BUT NOT

LEARN IN MEDICAL SCHOOL===3}add your experince of PLACEBO====may i help

you=======NOCEBO=====may i harm you.

On Tue, 15 Jun 2010 22:36:14 +0530 wrote

>

Dear Dr.ArinThank you for commenting on the point which I raised.

Unfortunately our moderator took it in a very light sense, if I am

right, as reflected in her words, quote, "medicine system should be

holistic. An

integrative approach comrising of allsystems of medicinelike

Ayurveda, Allopathic, Homeopathic, Siddha, Chinese...should be

adopted." unquote. Shemisinterprets holism (which itself is an obsolete

word) as an integration of all systems!! I can suggest

abeautifulbookfor further reading to the group members.title: WHAT

DOCTORS DON'T GET TO STUDY IN MEDICAL SCHOOLSautjor: Dr. B M HEGDEPub:

PARAS, HYDERABAD

With wishes prayersVaidya Prasad M.

From: anupama sukhlecha

Subject: New

discussion-PE: Is it improving medicine affordability?

netrumgroups (DOT) com

Date: Sunday, 13 June, 2010, 5:53 AM

Dear NetRUMians,

Welcome to all of you on another topic of discussion. I am Dr Anupama,

Assistant Professor in Pharmacology at Jamnagar. I shall be moderating

this new topic "PE: Is it improving medicine affordability" for the

next few days.

Background:

In low and middle-income countries a large proportion of the

population live in poverty and their condition is characterized by high

rates of mortality, morbidity and disability, as well as limited access

or none to health care and services. Prescription drug costs have risen

rapidly in the last decade. Inability to pay for medications has

consequences for population health and health system costs. A large

population of India is unable to afford the prescribed medicines. There

are plenty of cases of cost-associated noncompliance.

Despite the increased world consumption of medicines, problems remain

in ensuring the availability and affordability of medicines, including

those which are essential for treating the majority of common diseases

prevailing in low and middle-income countries.

On the first day of our discussion, let us look at the problems which

influence availability and affordability of medicines.

Surprise gifts assured for active contributors of discussion!

Waiting for your valuable inputs

Anupama Sukhlecha

Jamnagar

Dr. Surendra Muralidhar Kulkarni phone 07232 252129 Yavatmal. Shri.Vasantrao Naik Govt. Medical College PHYSIOLOGY DEPT. ASSO. PROF.Mob.08087121698.PIN 445001